近期,清华大学第一附属医院北京华信医院药学部研究人员发表《奥硝唑注射液致固定性药疹1例》研究,该文章发表于2015年1期的《中国药物应用与监测》上。
近期,清华大学第一附属医院北京华信医院药学部研究人员发表《奥硝唑注射液致固定性药疹1例》研究,该文章发表于2015年1期的《中国药物应用与监测》上。
1例80岁女性患者1年前行胆囊切除术,近日因胆道感染、反流性食管炎、冠状动脉粥样硬化性心脏病等入院治疗。给予奥硝唑注射液(0.5 g,bid,ivgtt)和头孢曲松(2 g,qd,ivgtt)进行抗感染,奥美拉唑钠(40 mg,bid,ivgtt)抑制胃酸治疗。用药第4天,患者双足出现多个水疱样固定性药疹。立即停用奥硝唑注射液,口服氯雷他定片(10 mg,qd),同时外用卤米松膏,抽疱湿敷治疗7 d后,患者双足固定性药疹结痂好转。
英文摘要:
One case of fixed drug eruption caused by ornidazole injection
Abstract: One 80-year-old female patient was hospitalized for biliary tract infection, reflux esophagitis, coronary atherosclerosis heart disease after cholecystectomy surgery 1 year ago. Ornidazole injection (0.5 g, bid, ivgtt) and ceftriaxone (2 g, qd, ivgtt) were used for anti-infection, omeprazole sodium (40 mg, bid, ivgtt) was utilized for gastric acid inhibition. On the fourth day, a few vesicular fixed drug eruptions occurred on the patient's feet. Ornidazole injection was stopped immediately, loratadine (10 mg, qd) and halometasone ointment were given. Suction blisters and wet for 7 days, the fixed drug eruption on the patient's feet began to escharosis and improved.
copyright©金宝搏网站登录技巧 版权所有,未经许可不得复制、转载或镜像
京ICP证120392号 京公网安备110105007198 京ICP备10215607号-1 (京)网药械信息备字(2022)第00160号